Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention

MLA

Gu Xinshun, et al. “Comparison of Usefulness of Simvastatin 20 Mg versus 80 Mg in Preventing Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.” The American Journal of Cardiology, vol. 104, no. 4, Dec. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b53470fdeaf43cb39287303ea8aa1387&authtype=sso&custid=ns315887.

APA

Gu Xinshun, Jiang Yunfa, Wu Weili, Hao Guozhen, Xue Ling, Jia Xinwei, Fan Weize, Zhang Jing, Li Shiqiang, & Fu Xianghua. (2008). Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. The American Journal of Cardiology, 104(4).

Chicago

Gu Xinshun, Jiang Yunfa, Wu Weili, Hao Guozhen, Xue Ling, Jia Xinwei, Fan Weize, Zhang Jing, Li Shiqiang, and Fu Xianghua. 2008. “Comparison of Usefulness of Simvastatin 20 Mg versus 80 Mg in Preventing Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.” The American Journal of Cardiology 104 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b53470fdeaf43cb39287303ea8aa1387&authtype=sso&custid=ns315887.